72 related articles for article (PubMed ID: 35503810)
21. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.
Raffetti E; Fattovich G; Donato F
Liver Int; 2016 Sep; 36(9):1239-51. PubMed ID: 27062182
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.
Wongjarupong N; Yonli AT; Nagalo BM; Djigma FW; Somda SK; Hassan MA; Mohamed EA; Sorgho AP; Compaore TR; Soubeiga ST; Kiendrebeogo I; Sanou M; Diarra B; Yang HI; Chen CJ; Ouattara AK; Zohoncon TM; Martinson JJ; Buetow K; Chamcheu JC; Antwi SO; Borad MJ; Simpore J; Roberts LR
Hepatol Commun; 2020 Dec; 4(12):1781-1792. PubMed ID: 33305149
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors.
Li W; Deng R; Liu S; Wang K; Sun J
Liver Int; 2020 Oct; 40(10):2316-2325. PubMed ID: 32666675
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Hepatocellular Carcinoma.
McGlynn KA; Petrick JL; El-Serag HB
Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):4-13. PubMed ID: 32319693
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B.
Voulgaris T; Papatheodoridi M; Lampertico P; Papatheodoridis GV
Liver Int; 2020 Mar; 40(3):484-495. PubMed ID: 31884726
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.
Batyrbekova N; Aleman S; Lybeck C; Montgomery S; Duberg AS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):63-70. PubMed ID: 31719064
[TBL] [Abstract][Full Text] [Related]
29. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease.
Taflin H; Hafström L; Holmberg E; Castedal M; Lindnér P
Scand J Gastroenterol; 2019 Jun; 54(6):746-752. PubMed ID: 31190577
[No Abstract] [Full Text] [Related]
30. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN
PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863
[TBL] [Abstract][Full Text] [Related]
31. Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.
An P; Xu J; Yu Y; Winkler CA
Front Genet; 2018; 9():261. PubMed ID: 30073017
[TBL] [Abstract][Full Text] [Related]
32. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
;
J Hepatol; 2018 Jul; 69(1):182-236. PubMed ID: 29628281
[No Abstract] [Full Text] [Related]
33. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
Marrero JA; Kulik LM; Sirlin CB; Zhu AX; Finn RS; Abecassis MM; Roberts LR; Heimbach JK
Hepatology; 2018 Aug; 68(2):723-750. PubMed ID: 29624699
[No Abstract] [Full Text] [Related]
34. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
Polaris Observatory Collaborators
Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):383-403. PubMed ID: 29599078
[TBL] [Abstract][Full Text] [Related]
35. The Swedish cause of death register.
Brooke HL; Talbäck M; Hörnblad J; Johansson LA; Ludvigsson JF; Druid H; Feychting M; Ljung R
Eur J Epidemiol; 2017 Sep; 32(9):765-773. PubMed ID: 28983736
[TBL] [Abstract][Full Text] [Related]
36. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection.
Mittal S; Kramer JR; Omino R; Chayanupatkul M; Richardson PA; El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):252-259. PubMed ID: 28870660
[TBL] [Abstract][Full Text] [Related]
37. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.
Yang JD; Mohamed EA; Aziz AO; Shousha HI; Hashem MB; Nabeel MM; Abdelmaksoud AH; Elbaz TM; Afihene MY; Duduyemi BM; Ayawin JP; Gyedu A; Lohouès-Kouacou MJ; Ndam AW; Moustafa EF; Hassany SM; Moussa AM; Ugiagbe RA; Omuemu CE; Anthony R; Palmer D; Nyanga AF; Malu AO; Obekpa S; Abdo AE; Siddig AI; Mudawi HM; Okonkwo U; Kooffreh-Ada M; Awuku YA; Nartey YA; Abbew ET; Awuku NA; Otegbayo JA; Akande KO; Desalegn HM; Omonisi AE; Ajayi AO; Okeke EN; Duguru MJ; Davwar PM; Okorie MC; Mustapha S; Debes JD; Ocama P; Lesi OA; Odeghe E; Bello R; Onyekwere C; Ekere F; Igetei R; Mah'moud MA; Addissie B; Ali HM; Gores GJ; Topazian MD; Roberts LR;
Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):103-111. PubMed ID: 28403980
[TBL] [Abstract][Full Text] [Related]
38. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.
Yang JD; Altekruse SF; Nguyen MH; Gores GJ; Roberts LR
Cancer; 2017 Jan; 123(1):81-89. PubMed ID: 27571320
[TBL] [Abstract][Full Text] [Related]
39. The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.
Törner A; Stokkeland K; Svensson Å; Dickman PW; Hultcrantz R; Montgomery S; Duberg AS
Hepatology; 2017 Mar; 65(3):885-892. PubMed ID: 27533761
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma: epidemiology and risk factors.
Kew MC
J Hepatocell Carcinoma; 2014; 1():115-25. PubMed ID: 27508181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
